Aotearoa Clinical Trials logo
Recruiting Trials
Search:

#TALK Research - Middlemore Clinical Trials Newsletter

Dec 13, 2021

December Edition of #TALK.Research 

Kia ora koutou and welcome to our December edition of #TALK.Research

Haematology is the focus for this newsletter as we acknowledge the exciting and ground breaking efforts of the Middlemore Hospital haematology department in making clinical trials available to their patients. Often clinical trials are the only way some patients can access novel agents that have the potential to  make a difference to the course of their disease.

The haematology department through their research reserve has spent over $400,000 ensuring that their patients can access some of this ground breaking research. For particular trials, our site may be the only haematological site available in the region. The numbers of haematological clinical trials is continuing to grow as is the excitement in the clinical outcomes they may deliver.

Hei konā mai,
 
Dr Edward Watson - CEO Middlemore Clinical Trials
What's in this issue:
  • Featured Department - Haematology 
  • NPSIMSTM Device Trial Update
  • Meet the Team - Emma Dorsey (Clinical Trial Coordinator)
  • MMCT is now on Twitter
  • Trials Starting at MMCT
  • Trial Stats 
  • Clinical Trial Referral App available to download

Featured Department - Haematology


The Haematology department at Middlemore Hospital are unique in that all six consultants are actively involved in clinical research. The Haematology team are dedicated to providing the best care for their patients and giving them the opportunity to participate in world-class clinical trial research right here in Counties Manukau. The team are very busy with a combination of commercial and grant-funded trials as well as their clinic responsibilities. In FY2020, the Haematology department received the most feasibilities for new trials and conducted the most trials.

The Haematology consultant team is led by Dr Sharon Jackson, and the haematologists are Dr Samar Issa, Dr Rajeev Rajagopal, Dr James Liang, Dr Gordon Royle, and Dr Kirsty Marshall. The research interests of the team include blood cancers (such as leukaemia, lymphomas, and multiple myelomas), myeloproliferative neoplasms and bleeding and coagulation disorders. The patients seen by the Haematology team often have very limited funded treatment options and so by taking part in a clinical trial they are able to access novel therapies long before they become standard of care treatments.

We are looking forward to working with the Haematology team in conducting a number of new exciting trials next year.
Click here to find out more
NPSIMSTM Device Trial Update

The Aatru Medical (LLC) NPSIMSTM Negative Pressure Surgical Incision Management System is a device designed to help reduce the rate of wound infection and seroma (build-up of fluid at surgical site). We are proud to have coordinated this first-in-human-open label clinical study with Principal Investigator Mr Jon Mathy in Plastic surgery and Mr Alpesh Patel in Spinal surgery.

The NPSIMSTM uses novel chemical reactions to apply negative pressure to closed incisions, and the interim analysis of the first five participants have showed promising results with no adverse events experienced by the participants. Dr Jon Mathy praises the device “These devices were easy to use and totally silent in operation. This new system has an innovative adhesive silicone gasket which facilitates seal, including around joints.”

We look forward to the completion of this trial and are excited about this novel technology that will hopefully prevent post-surgical infections.

Read more about the interim analysis here.

Middlemore Clinical Trials is now on Twitter!

Twitter is a great way for Counties Manukau staff to stay updated with the trials that are being conducted right here at Middlemore Hospital.

Follow us and our researchers on Twitter to stay updated with the latest trial news!
 
Follow MMCT on Twitter
Meet the Team Emma Dorsey (Clinical Trial Coordinator)
 
Emma has a Master of Science degree, majoring in biochemistry. She has a background in academic research with interests in medical biochemistry; protein structure and function; and genomics.

She has experience as a Visiting Scientist at UT Health, San Antonio and also in project coordination and management. She is looking forward to diving into the world of clinical trial research and developing a new skillset.

Emma has taken on the role as the interim Recruitment Lead, please join us in welcoming Emma to her new role.
To learn more about the trials we are performing at Middlemore Hospital, please visit our website and see what trials in what disease areas we are currently working on.
 
Together through research we can improve the lives of many of the patients in Counties Manukau.
View Current Recruiting Trials

Trials starting at MMCT 

List of upcoming trials that are planned to start recruiting in the next three months:
 
NEW: Clinical Trial Referral App available to download. Stay up to date for clinical trials recruiting at Middlemore Hospital
Scan the QR Code to Download the ClinTrial Refer App
MMCT Contacts
 
Type of Enquiry Person Email Address
Feasibilities Kate Msiska  feasibility@mmclintrials.nz
Trial Contracts Kate Msiska  contracts@mmclintrials.nz
Finance Emani Setefano  finance@mmclintrials.nz  
Investigator Initiated (Grant Funded) Trials Dr Nicola Jackson
Dr Dharshini Sreenivasan
grants@mmclintrials.nz
Regulatory/Ethics Catherine Howie  ethics@mmclintrials.nz
For support when a clinically significant event occurs with a trial Dr John Baker  John.Baker@mmclintrials.nz
To refer a patient for a clinical trial Please visit our website or use the ClinTrial Refer App Recruiting Trials Page
Emma.Dorsey@mmclintrials.nz
Facebook
Twitter
Website
LinkedIn